For citations:
Yudin DI, Laktionov КК, Breder VV, Sarantseva KA, Reutova EV. Immune Checkpoint Inhibitors in first versus second line of metastatic non-small cell lung cancer: Real-World Overall Survival. Meditsinskiy sovet = Medical Council. 2024;(10):132-137. (In Russ.) https://doi.org/10.21518/ms2024-219